Influenza Diagnostics Market Intelligence with Competitive Landscape 2023

June 14, 2018 | Author: | Posted in Health, Health-Fitness

This photograph of CDC’s Dr. Terrence Tumpey, Microbiologist for the National Center for Infectious Diseases, shows him examining specimens of the 1918 Pandemic Influenza Virus—a virus that was reconstructed in hopes of combating a future influenza pandemic.
Dr. Tumpey recreated the 1918 influenza virus to identify the characteristics that made the 1918 influenza virus so harmful. This effort enables researchers to develop new vaccines and treatments for future pandemic influenza viruses.
The 1918 flu epidemic was caused by an influenza A virus (H1N1), killing more than 500,000 people in the United States, and up to 50 million worldwide. Many people died within the first few days after infection, and others died of complications later. Nearly half of those who died were young, healthy adults. Influenza A (H1N1) viruses still circulate today after being introduced again into the human population in the 1970s.
Date: 2005
Content credits: / xxxxx
Photo credit: James Gathany
Image storage: xxxxxxxxxxxxx
Support File: CD_122_DH/ 012
CDC – Office of Communication – Media Release – 1918 Influenza Virus
CDC – Information about Influenza Pandemics

Industry Trend Analysis:
The Influenza Diagnostics Market was worth USD 0.42 billion in 2014 and is expected to reach approximately USD 0.88 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.45% during the forecast period.

Browse Full Report @ .

Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza.

Test Type Outlook and Trend Analysis:
According to the Type the market of Influenza Diagnostics is divided into Traditional and Molecular. Rapid Influenza Detection Test (RIDT) constituted the major share of the market due to its benefits such as quick results, user friendly, etc. The RIDT is expected to continue growing during the forecast period. The Molecular test types segment is also further divided into Nucleic Acid Sequence-Based Amplification (NASBA), RT-PCR, Loop-Mediated Isothermal Amplification-Based Assays (LAMP), and Simple Amplification-Based Assays (SAMBA). Due to its ability to distinguish between Influenza A & B viruses the RT-PCR is the most widely used Molecular test.

Table of Contents:
2.Executive Summary
3.Market Overview
4.Market Analysis by Regions

4.1.North America (United States, Canada and Mexico)
4.1.1.United States Market States and Outlook (2014-2023)
4.1.2.Canada Market States and Outlook (2014-2023)
4.1.3.Mexico Market States and Outlook (2014-2023)
4.2.Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1.Germany Market States and Outlook (2014-2023)
4.2.2.France Market States and Outlook (2014-2023)
4.2.3.UK Market States and Outlook (2014-2023)
4.2.4.Russia Market States and Outlook (2014-2023)
4.2.5.Italy Market States and Outlook (2014-2023)
4.2.6.Rest of Europe Market States and Outlook (2014-2023)
4.3.Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1.China Market States and Outlook (2014-2023)
4.3.2.Japan Market States and Outlook (2014-2023)
4.3.3.Korea Market States and Outlook (2014-2023)
4.3.4.India Market States and Outlook (2014-2023)
4.3.5.Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4.South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1.Brazil Market States and Outlook (2014-2023)
4.4.2.Argentina Market States and Outlook (2014-2023)
4.4.3.Columbia Market States and Outlook (2014-2023)
4.4.4.Rest of South America Market States and Outlook (2014-2023)
4.5.Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1.Saudi Arabia Market States and Outlook (2014-2023)
4.5.2.UAE Market States and Outlook (2014-2023)
4.5.3.Egypt Market States and Outlook (2014-2023)
4.5.4.Nigeria Market States and Outlook (2014-2023)
4.5.5.South Africa Market States and Outlook (2014-2023)
4.5.6.Rest of MEA Market States and Outlook (2014-2023)
5.Influenza Diagnostics Market, By Traditional Test Type
5.2.Global Influenza Diagnostics Sales, Revenue and Market Share By Traditional Test Type (2014-2018)
5.2.1.Global Influenza Diagnostics Sales and Sales Share By Traditional Test Type (2014-2018)
5.2.2.Global Influenza Diagnostics Revenue and Revenue Share By Traditional Test Type (2014-2018)
5.3.Traditional Viral Culture
5.3.1.Global Traditional Viral Culture Sales and Growth Rate (2014-2018)
5.4.Serology Test
5.4.1.Global Serology Test Sales and Growth Rate (2014-2018)
5.5.Rapid Influenza Detection Test
5.5.1.Global Rapid Influenza Detection Test Sales and Growth Rate (2014-2018)
5.6.1.Global DFA Culture Sales and Growth Rate (2014-2018)
To be Continued…

Get Sample Copy of This Report @ .

Regional Outlook and Trend Analysis:
According to the region, the Influenza Diagnostics Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The Europe regions accounts to the majority of the share in the Influenza Diagnostics Market due to increasing population and also rising incidents of influenza diseases. The North-America region is the second largest market for Influenza Diagnostics followed by Asia-Pacific which is expected to grow at the highest CAGR during the forecast owing to increased expenditure, rising influenza incidents, etc.

End User Method Outlook and Trend Analysis:
The End-User segment is fragmented into Hospitals & Clinics, Reference lab, POC, Home Care Agency. The Hospitals and Clinics segments amongst the End-User segments are prominent due to extensive use of these tests in diagnostics of influenza which are mostly carried out there.

The Influenza Diagnostics Market is segmented as follows-

By Natural Test Type:
Traditional Viral Culture
Serology Test
Rapid Influenza Detection Test

By Molecular Test Type:
Nucleic Acid Sequence-Based Amplification (NASBA)
Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-Based Assays (SAMBA)

By End User:
Reference lab
Home Care Agency

Competitive Insights:
The leading players in the market are Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company.

Make an Inquiry @ .

About Crystal Market Research:
Crystal Market Research
is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

Facebook Comments


This author has published 95 articles so far. More info about the author is coming soon.

Leave a Reply

You must be logged in to post a comment.